Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2025)

Coya Therapeutics' Asset Utilization Ratio history spans 3 years, with the latest figure at 0.12 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 51.89% year-over-year to 0.12; the TTM value through Sep 2025 reached 0.12, down 51.89%, while the annual FY2024 figure was 0.08, 65.65% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.12 at Coya Therapeutics, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.25 in Q3 2024 and bottomed at 0.01 in Q2 2025.
  • The 3-year median for Asset Utilization Ratio is 0.14 (2024), against an average of 0.15.
  • The largest YoY upside for Asset Utilization Ratio was 42.85% in 2025 against a maximum downside of 95.23% in 2025.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.23 in 2023, then crashed by 60.61% to 0.09 in 2024, then surged by 36.88% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Asset Utilization Ratio are 0.12 (Q3 2025), 0.01 (Q2 2025), and 0.09 (Q1 2025).